SHERMAN MARK ANDREW 4
4 · Dolby Laboratories, Inc. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
SHERMAN MARK ANDREW
EVP, GEN. COUN. & SECRTY
Transactions
- Exercise/Conversion
Class A Common Stock
2025-12-01$64.60/sh+4,500$290,700→ 66,897 total - Sale
Class A Common Stock
2025-12-01$67.56/sh−4,500$304,036→ 62,397 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-12-01−4,500→ 0 totalExercise: $64.60Exp: 2025-12-17→ Class A Common Stock (4,500 underlying)
Footnotes (3)
- [F1]Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- [F2]The shares were sold in multiple transactions at prices ranging from $67.115 to $67.95, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 19,500 shares.